You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global and United States Actinic Keratosis Treatment Market Size, Status and Forecast 2021-2027

Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.

In North America actinic keratosis treatment main manufactuers include DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, Bausch Health, Taro Pharmaceutical, Galderma (Nestle), Biofrontera, Almirall and Tolmar Pharmaceutical, etc.,totally accounting for about 11% of the market. As for the types of products, it can be divided into destructive treatment, photodynamic therapy, topical medications and others. The most common product is destructive treatment, with a share over 80%. In terms of applications, it is widely used in hospitals, clinics and others. The most commom application is in clinics, with a share over 63%.
Market Analysis and Insights: Global Actinic Keratosis Treatment Market
The global Actinic Keratosis Treatment market size is projected to reach US$ 4521.5 million by 2027, from US$ 3142 million in 2020, at a CAGR of 5.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Actinic Keratosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Actinic Keratosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Actinic Keratosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Actinic Keratosis Treatment market.
Actinic Keratosis Treatment Breakdown Data by Type
Destructive Treatment
Photodynamic Therapy
Topical Medications
Actinic Keratosis Treatment Breakdown Data by Application
Based on regional and country-level analysis, the Actinic Keratosis Treatment market has been segmented as follows:
North America
United States
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
Latin America
Middle East & Africa
Saudi Arabia
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Actinic Keratosis Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.

The following players are covered in this report:
DUSA Pharmaceuticals
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Tolmar Pharmaceutical

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Actinic Keratosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Destructive Treatment
1.2.3 Photodynamic Therapy
1.2.4 Topical Medications
1.2.5 Others
1.3 Market by Application
1.3.1 Global Actinic Keratosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Actinic Keratosis Treatment Market Perspective (2016-2027)
2.2 Actinic Keratosis Treatment Growth Trends by Regions
2.2.1 Actinic Keratosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Actinic Keratosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Actinic Keratosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Actinic Keratosis Treatment Industry Dynamic
2.3.1 Actinic Keratosis Treatment Market Trends
2.3.2 Actinic Keratosis Treatment Market Drivers
2.3.3 Actinic Keratosis Treatment Market Challenges
2.3.4 Actinic Keratosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Actinic Keratosis Treatment Players by Revenue
3.1.1 Global Top Actinic Keratosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Actinic Keratosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Actinic Keratosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Actinic Keratosis Treatment Revenue
3.4 Global Actinic Keratosis Treatment Market Concentration Ratio
3.4.1 Global Actinic Keratosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Actinic Keratosis Treatment Revenue in 2020
3.5 Actinic Keratosis Treatment Key Players Head office and Area Served
3.6 Key Players Actinic Keratosis Treatment Product Solution and Service
3.7 Date of Enter into Actinic Keratosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Actinic Keratosis Treatment Breakdown Data by Type
4.1 Global Actinic Keratosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Actinic Keratosis Treatment Forecasted Market Size by Type (2022-2027)

5 Actinic Keratosis Treatment Breakdown Data by Application
5.1 Global Actinic Keratosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Actinic Keratosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Actinic Keratosis Treatment Market Size (2016-2027)
6.2 North America Actinic Keratosis Treatment Market Size by Type
6.2.1 North America Actinic Keratosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Actinic Keratosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Actinic Keratosis Treatment Market Size by Type (2016-2027)
6.3 North America Actinic Keratosis Treatment Market Size by Application
6.3.1 North America Actinic Keratosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Actinic Keratosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Actinic Keratosis Treatment Market Size by Application (2016-2027)
6.4 North America Actinic Keratosis Treatment Market Size by Country
6.4.1 North America Actinic Keratosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Actinic Keratosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Actinic Keratosis Treatment Market Size (2016-2027)
7.2 Europe Actinic Keratosis Treatment Market Size by Type
7.2.1 Europe Actinic Keratosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Actinic Keratosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Actinic Keratosis Treatment Market Size by Type (2016-2027)
7.3 Europe Actinic Keratosis Treatment Market Size by Application
7.3.1 Europe Actinic Keratosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Actinic Keratosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Actinic Keratosis Treatment Market Size by Application (2016-2027)
7.4 Europe Actinic Keratosis Treatment Market Size by Country
7.4.1 Europe Actinic Keratosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Actinic Keratosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Actinic Keratosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Type
8.2.1 Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Actinic Keratosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Actinic Keratosis Treatment Market Size by Application
8.3.1 Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Actinic Keratosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Actinic Keratosis Treatment Market Size by Region
8.4.1 Asia-Pacific Actinic Keratosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Actinic Keratosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Actinic Keratosis Treatment Market Size (2016-2027)
9.2 Latin America Actinic Keratosis Treatment Market Size by Type
9.2.1 Latin America Actinic Keratosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Actinic Keratosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Actinic Keratosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Actinic Keratosis Treatment Market Size by Application
9.3.1 Latin America Actinic Keratosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Actinic Keratosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Actinic Keratosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Actinic Keratosis Treatment Market Size by Country
9.4.1 Latin America Actinic Keratosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Actinic Keratosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Actinic Keratosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Type
10.2.1 Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Actinic Keratosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Actinic Keratosis Treatment Market Size by Application
10.3.1 Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Actinic Keratosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Actinic Keratosis Treatment Market Size by Country
10.4.1 Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Actinic Keratosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 DUSA Pharmaceuticals
11.1.1 DUSA Pharmaceuticals Company Details
11.1.2 DUSA Pharmaceuticals Business Overview
11.1.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Introduction
11.1.4 DUSA Pharmaceuticals Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.1.5 DUSA Pharmaceuticals Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Actinic Keratosis Treatment Introduction
11.2.4 Novartis Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Perrigo
11.3.1 Perrigo Company Details
11.3.2 Perrigo Business Overview
11.3.3 Perrigo Actinic Keratosis Treatment Introduction
11.3.4 Perrigo Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.3.5 Perrigo Recent Development
11.4 LEO Pharma
11.4.1 LEO Pharma Company Details
11.4.2 LEO Pharma Business Overview
11.4.3 LEO Pharma Actinic Keratosis Treatment Introduction
11.4.4 LEO Pharma Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.4.5 LEO Pharma Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Details
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Actinic Keratosis Treatment Introduction
11.5.4 Bausch Health Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.5.5 Bausch Health Recent Development
11.6 Taro Pharmaceutical
11.6.1 Taro Pharmaceutical Company Details
11.6.2 Taro Pharmaceutical Business Overview
11.6.3 Taro Pharmaceutical Actinic Keratosis Treatment Introduction
11.6.4 Taro Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.6.5 Taro Pharmaceutical Recent Development
11.7 Galderma (Nestle)
11.7.1 Galderma (Nestle) Company Details
11.7.2 Galderma (Nestle) Business Overview
11.7.3 Galderma (Nestle) Actinic Keratosis Treatment Introduction
11.7.4 Galderma (Nestle) Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.7.5 Galderma (Nestle) Recent Development
11.8 Biofrontera
11.8.1 Biofrontera Company Details
11.8.2 Biofrontera Business Overview
11.8.3 Biofrontera Actinic Keratosis Treatment Introduction
11.8.4 Biofrontera Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.8.5 Biofrontera Recent Development
11.9 Almirall
11.9.1 Almirall Company Details
11.9.2 Almirall Business Overview
11.9.3 Almirall Actinic Keratosis Treatment Introduction
11.9.4 Almirall Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.9.5 Almirall Recent Development
11.10 Tolmar Pharmaceutical
11.10.1 Tolmar Pharmaceutical Company Details
11.10.2 Tolmar Pharmaceutical Business Overview
11.10.3 Tolmar Pharmaceutical Actinic Keratosis Treatment Introduction
11.10.4 Tolmar Pharmaceutical Revenue in Actinic Keratosis Treatment Business (2016-2021)
11.10.5 Tolmar Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140